Cannabidiol not effective in treatment-resistant schizophrenia
Thursday, August 31st, 2006
Here is another in our ongoing series on recent marijuana-related medical research.
Cannabidiol (CBD) is a major product of the marijuana plant. It lacks marijuana’s psychological effects, and it has been suggested that CBD might be effective as an antipsychotic. The aim of this study was to investigate the response to CBD in treatment-resistant schizophrenia.
For this study, researchers created a computer-simulated community of 100,000 people that resembled the population of Olmsted County, Minnesota, in 2000.
It has everything needed to become a cult health food icon.
This is a bit technical, but I think it’s important because it documents the ability of peppermint to act as an antispasmodic agent in the small intestine.
According to the distributor’s
The latest issue of the International Journal of Impotence Research included several articles of interest from a CAM perspective,